These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16414268)

  • 1. Mechanisms for inducing nasal mucosal tolerance in experimental autoimmune uveoretinitis.
    Calder CJ; Nicholson LB; Dick AD
    Methods; 2006 Feb; 38(2):69-76. PubMed ID: 16414268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
    Avichezer D; Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):127-31. PubMed ID: 10634611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping immune responses to mRBP-3 1-16 peptide with altered peptide ligands.
    Guyver CJ; Copland DA; Calder CJ; Sette A; Sidney J; Dick AD; Nicholson LB
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2027-35. PubMed ID: 16639012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice.
    Jiang HR; Lumsden L; Forrester JV
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3177-85. PubMed ID: 10586940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental autoimmune uveoretinitis by regulatory dendritic cells in mice.
    Usui Y; Takeuchi M; Hattori T; Okunuki Y; Nagasawa K; Kezuka T; Okumura K; Yagita H; Akiba H; Goto H
    Arch Ophthalmol; 2009 Apr; 127(4):514-9. PubMed ID: 19365033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells.
    Jiang HR; Muckersie E; Robertson M; Forrester JV
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1598-607. PubMed ID: 12657598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis.
    Usui Y; Akiba H; Takeuchi M; Kezuka T; Takeuchi A; Hattori T; Okunuki Y; Yamazaki T; Yagita H; Usui M; Okumura K
    Eur J Immunol; 2006 Nov; 36(11):3071-81. PubMed ID: 17039566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
    Kitamei H; Iwabuchi K; Namba K; Yoshida K; Yanagawa Y; Kitaichi N; Kitamura M; Ohno S; Onoé K
    J Leukoc Biol; 2006 Jun; 79(6):1193-201. PubMed ID: 16574770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis.
    Gregerson DS; Torseth JW; McPherson SW; Roberts JP; Shinohara T; Zack DJ
    J Immunol; 1999 Jul; 163(2):1073-80. PubMed ID: 10395707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations.
    Kerr EC; Raveney BJ; Copland DA; Dick AD; Nicholson LB
    J Autoimmun; 2008 Dec; 31(4):354-61. PubMed ID: 18838247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis.
    Yoshimura T; Sonoda KH; Miyazaki Y; Iwakura Y; Ishibashi T; Yoshimura A; Yoshida H
    Int Immunol; 2008 Feb; 20(2):209-14. PubMed ID: 18156624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rodent models of experimental autoimmune uveitis.
    Agarwal RK; Caspi RR
    Methods Mol Med; 2004; 102():395-419. PubMed ID: 15286397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of interferon-beta suppresses experimental autoimmune uveoretinitis.
    Suzuki J; Sakai J; Okada AA; Takada E; Usui M; Mizuguchi J
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):314-21. PubMed ID: 11981647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine respiratory tract dendritic cells: isolation, phenotyping and functional studies.
    Calder CJ; Liversidge J; Dick AD
    J Immunol Methods; 2004 Apr; 287(1-2):67-77. PubMed ID: 15099756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals.
    Thurau SR; Chan CC; Nussenblatt RB; Caspi RR
    Clin Exp Immunol; 1997 Aug; 109(2):370-6. PubMed ID: 9276535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis.
    Martín AP; de Moraes LV; Tadokoro CE; Commodaro AG; Urrets-Zavalia E; Rabinovich GA; Urrets-Zavalia J; Rizzo LV; Serra HM
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2056-63. PubMed ID: 15914623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunomodulator vasoactive intestinal peptide (VIP) does not affect experimental autoimmune uveitis (EAU) in B10.RIII mice.
    Chen J; Vistica B; Wiggert B; Chan CC; Gery I
    Ocul Immunol Inflamm; 2005 Feb; 13(1):13-7. PubMed ID: 15804764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.
    George Chandy A; Hultkrantz S; Raghavan S; Czerkinsky C; Lebens M; Telemo E; Holmgren J
    Immunology; 2006 Jul; 118(3):311-20. PubMed ID: 16827892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.